Sinsin Pharmaceutical Co (XKRX:002800) 3-Year EBITDA Growth Rate : 58.00% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sinsin Pharmaceutical Co 3-Year EBITDA Growth Rate?

Sinsin Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2024 was ₩150.30.

During the past 12 months, Sinsin Pharmaceutical Co's average EBITDA Per Share Growth Rate was 15.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 58.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 34.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sinsin Pharmaceutical Co was 58.00% per year. The lowest was -27.20% per year. And the median was -1.75% per year.

Competitive Comparison of Sinsin Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sinsin Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinsin Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinsin Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sinsin Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Sinsin Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sinsin Pharmaceutical Co (XKRX:002800) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sinsin Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sinsin Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinsin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinsin Pharmaceutical Co Ltd (XKRX:002800) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

776-6, Wonsi-Dong, Danwon-Ku, Kyunggi-Do, Ansan City, KOR

Website

http://www.sinsin.com

Sinsin Pharmaceutical Co Ltd is a pharmaceutical company, which manufactures and sells pharmaceutical products in South Korea. It offers pain relief and treatment products, including pain relief patches, creams, and sprays; insects care products, such as mosquito repellents and anti-perspirants; foot care products; head lice and dandruff care products; protection bands; and other products.

Sinsin Pharmaceutical Co Headlines

No Headlines